Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165
PaperCitations, authors & open-access status
Highly Selective Inhibition of Tyrosine Kinase 2 (TYK2) for the Treatment of Autoimmune Diseases: Discovery of the Allosteric Inhibitor BMS-986165 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 378 citations, 2019 year and green oa status.
378
Citations
2019
Year
green
OA Status